Sort
141,003 grants matching “cytokine”
Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure
$658,442Yu-Long Li · University Of Nebraska Medical Center · R01 · FY2023 · HL
Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations
$658,437Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Chronic STAT3 signaling in STAT3 GOF causes CD8 T cell dysfunction via CD39 upregulation
$658,426Sarah E Henrickson · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Engineering T Cell Adoptive Therapy for Glioblastoma
$658,407Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS
Developing Safe and Effective GD2-CAR T Cell Therapy for Diffuse Midline Gliomas
$658,390Crystal Mackall · Stanford University · R01 · FY2023 · CA
Translation & trials: advancing medical countermeasure development
$658,367Kurt Lu · Northwestern University At Chicago · U54 · FY2022 · AR
Role of Costimulation in Control of the Effector and Regulatory T Cell Balance
$658,362Arlene H Sharpe · Yale University · P01 · FY2014 · AI
Immune Mechanism of Rejection in Human Lung Allografts
$658,333Thalachallour Mohanakumar · Washington University · R01 · FY2012 · HL
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$658,328Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
$658,328Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Targeting myeloid cells for regulation of alum-based immunity
$658,306Prosper N Boyaka · Ohio State University · R01 · FY2020 · AI
Epigenetic Changes associated with Neurodegenerative Diseases
$658,267Shelley L Berger · University Of Pennsylvania · R01 · FY2012 · NS
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction
$658,263Charles A Parkos · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Neuropeptide-mediated regulation of antihelminth immunity
$658,262Mark Christopher Siracusa · Rbhs-New Jersey Medical School · R01 · FY2020 · AI
Autophagy Against Tuberculosis and HIV
$658,214Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2017 · AI
Autophagy Against Tuberculosis and HIV
$658,214Vojo P Deretic · University Of New Mexico Health Scis Ctr · R01 · FY2018 · AI
Role of altered gut immune response in Lewy Body Disease
$658,194Kathleen Lombard Poston · Stanford University · U01 · FY2025 · DK
Regional Tidal Lung Strain and Neutrophilic Inflammation in Early Lung Injury
$658,190Marcos F Vidal Melo · Massachusetts General Hospital · R01 · FY2014 · HL
Accelerated Inflammaging in Schizophrenia
$658,147Dilip V Jeste · University Of California, San Diego · R01 · FY2018 · MH
Physiology of Unloading VA ECMO Trial
$658,132Joseph Edward Tonna · University Of Utah · R01 · FY2024 · HL
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
$658,092Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2023 · CA
Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease
$658,089Lee Armistead Denson · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HD
Prevention of Lung Transplant Injury with Adenosine 2A Receptor Agonist
$658,033Christine L Lau · University Of Virginia · R01 · FY2017 · HL
Discovery and Analysis of Synthetic TLR Agonists and Antagonists
$658,004Bruce A Beutler · Scripps Research Institute, The · U24 · FY2010 · AI
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$657,991Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA